Ridinilazole
Ridinilazole is an investigational antibiotic currently in development for the treatment of Clostridium difficile infection (CDI). It is being developed by Summit Therapeutics, a UK-based pharmaceutical company.
Mechanism of Action[edit | edit source]
Ridinilazole is a narrow-spectrum antibiotic that selectively targets Clostridium difficile, the bacteria responsible for causing CDI. It works by inhibiting the synthesis of bacterial DNA, thereby preventing the bacteria from multiplying and spreading.
Clinical Trials[edit | edit source]
Ridinilazole has undergone Phase 2 clinical trials, where it demonstrated superiority over vancomycin, a commonly used antibiotic for CDI, in terms of sustained clinical response. Phase 3 trials are currently underway to further evaluate the efficacy and safety of Ridinilazole.
Potential Advantages[edit | edit source]
Ridinilazole's narrow-spectrum activity could potentially reduce the risk of antibiotic resistance and preserve the gut microbiota, which is often disrupted by broad-spectrum antibiotics. This could potentially lead to better patient outcomes and lower recurrence rates.
Potential Side Effects[edit | edit source]
As with all medications, Ridinilazole may cause side effects. The most common side effects observed in clinical trials include nausea, vomiting, and abdominal pain. However, these side effects were generally mild and transient.
See Also[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
